Merck (MRK) Other Operating Expenses (2010 - 2026)

Merck (MRK) has 17 years of Other Operating Expenses data on file, last reported at $4.3 billion in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $4.3 billion, up 28.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.2 billion (up 41.05% YoY), and the FY2025 annual result was $16.5 billion, up 8.99% from the prior year.
• Other Operating Expenses eased to $4.3 billion in Q1 2026 per MRK's latest filing, from $9.7 billion in the prior quarter.
• Over five years, Other Operating Expenses peaked at $9.7 billion in Q4 2025 and troughed at $3.4 billion in Q1 2025.
• A 5-year average of $4.7 billion and a median of $4.0 billion in 2023 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses sank 51.28% in 2024, then soared 145.74% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $3.8 billion in 2022, then soared by 113.27% to $8.1 billion in 2023, then sank by 51.28% to $4.0 billion in 2024, then soared by 145.74% to $9.7 billion in 2025, then slumped by 55.42% to $4.3 billion in 2026.
• Business Quant data shows MRK's Other Operating Expenses at $4.3 billion in Q1 2026, $9.7 billion in Q4 2025, and $3.6 billion in Q3 2025.